Injectable Drug Delivery Market - New Industry Research Report Is Now Available for Pre-Order at Transparency Market Research
Albany, NY (PRWEB) July 31, 2013 -- Injectable drug delivery is defined as the introduction of a drug or drugs into the patient by using a delivery device. Injectables allow the transport of drugs formulated in liquid form, directly in the body, and they may be designed to transport the drug to specific part of the body.
Some of the major factors driving the growth of injectables are an increase in the number of cancer and diabetic patients globally, improved patient compliance to drug delivery system and technology advancement. Out of the all the segments of this market, the formulation technologies market occupies a major share globally due to the rapid development of nanotechnologies. The key deterrents restraining the growth of the global injectables market include patient safety issues, injuries caused while administering injectables, development of alternate drug delivery methods and product recalls.
Related Report: Anti-Infectives Market
http://www.transparencymarketresearch.com/anti-infectives-market.html
The global injectable drug delivery market is dominated by North America and is followed by Europe. However, the North American region lags behind the European injectable market in self-injection devices due to the low penetration rate of pen injectors in the U.S. The emerging Asian and Latin American countries collectively represent the fastest growing market for injectables due to the increase in incidences of cancer and diabetes in patients and also their compliance to novel technologies. Furthermore, the drug and device manufacturers are focusing on major emerging injectables market of Asia and Latin America due to the less stringent regulations for acquiring approvals on devices and less competition.
Some of the key players in the injectables drug delivery technology market are Becton, Dickinson and Company, Baxter International, Inc., Scandinavian Health Limited, Ypsomed Holding AG, Terumo Medical Corp., Schott AG, Owen Mumford Ltd., Antares Pharma, Inc., Eli Lilly And Company and Zogenix, Inc.
Browse the blog: http://tmrmarketresearch.blogspot.com/
This report is a complete study of current trends in the market, industry growth drivers, and restraints. It provides market projections for the coming years. It includes analysis of recent developments in technology, Porter’s five force model analysis and detailed profiles of top industry players. The report also includes a review of micro and macro factors essential for the existing market players and new entrants along with detailed value chain analysis.
Browse the full report with Request TOC at http://www.transparencymarketresearch.com/injectable-drug-delivery-market.html
Reasons for Buying this Report
This report provides pin-point analysis for changing competitive dynamics
It provides a forward looking perspective on different factors driving or restraining market growth
It provides a technological growth map over time to understand the industry growth rate
It provides a seven-year forecast assessed on the basis of how the market is predicted to grow
It helps in understanding the key product segments and their future
It provides pin point analysis of changing competition dynamics and keeps you ahead of competitors
It helps in making informed business decisions by having complete insights of market and by making in-depth analysis of market segments
It provides distinctive graphics and exemplified SWOT analysis of major market segments
Browse All Market Research Reports: http://www.transparencymarketresearch.com/
Sheela AK, Transparency Market Research, http://www.transparencymarketresearch.com, +1-518-618-1030, [email protected]
Share this article